Mona El‐Bahrawy

5.3k total citations
88 papers, 2.5k citations indexed

About

Mona El‐Bahrawy is a scholar working on Molecular Biology, Reproductive Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mona El‐Bahrawy has authored 88 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 31 papers in Reproductive Medicine and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mona El‐Bahrawy's work include Ovarian cancer diagnosis and treatment (29 papers), Wnt/β-catenin signaling in development and cancer (10 papers) and Renal cell carcinoma treatment (8 papers). Mona El‐Bahrawy is often cited by papers focused on Ovarian cancer diagnosis and treatment (29 papers), Wnt/β-catenin signaling in development and cancer (10 papers) and Renal cell carcinoma treatment (8 papers). Mona El‐Bahrawy collaborates with scholars based in United Kingdom, Egypt and United States. Mona El‐Bahrawy's co-authors include Richard Poulsom, Malcolm Alison, Hani Gabra, Silvia von Karstedt, Henning Walczak, Antonella Montinaro, Massimo Pignatelli, Patrick J. Pollard, Robert Brown and Eric W.‐F. Lam and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Circulation.

In The Last Decade

Mona El‐Bahrawy

87 papers receiving 2.5k citations

Peers

Mona El‐Bahrawy
Hanbyoul Cho South Korea
Ricardo R. Lastra United States
Roberto Dina United Kingdom
H. Kölbl Germany
Hanbyoul Cho South Korea
Mona El‐Bahrawy
Citations per year, relative to Mona El‐Bahrawy Mona El‐Bahrawy (= 1×) peers Hanbyoul Cho

Countries citing papers authored by Mona El‐Bahrawy

Since Specialization
Citations

This map shows the geographic impact of Mona El‐Bahrawy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona El‐Bahrawy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona El‐Bahrawy more than expected).

Fields of papers citing papers by Mona El‐Bahrawy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona El‐Bahrawy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona El‐Bahrawy. The network helps show where Mona El‐Bahrawy may publish in the future.

Co-authorship network of co-authors of Mona El‐Bahrawy

This figure shows the co-authorship network connecting the top 25 collaborators of Mona El‐Bahrawy. A scholar is included among the top collaborators of Mona El‐Bahrawy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona El‐Bahrawy. Mona El‐Bahrawy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yagüe, Ernesto, et al.. (2024). Exploring the histogenesis of STK11 adnexal tumour using electron microscopy. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(4). 683–690. 3 indexed citations
2.
Kasaven, Lorraine, Benjamin P. Jones, M. Al‐Memar, et al.. (2022). Fertility Sparing Surgery and Borderline Ovarian Tumours. Cancers. 14(6). 1485–1485. 9 indexed citations
3.
Montinaro, Antonella, Anna-Laura Kretz, Rute M. M. Ferreira, et al.. (2021). Potent pro-apoptotic combination therapy is highly effective in a broad range of cancers. Cell Death and Differentiation. 29(3). 492–503. 12 indexed citations
4.
Stronach, Euan A., James Paul, Kirsten M. Timms, et al.. (2018). Biomarker Assessment of HR Deficiency, Tumor BRCA1/2 Mutations, and CCNE1 Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following Platinum Monotherapy. Molecular Cancer Research. 16(7). 1103–1111. 81 indexed citations
5.
Blagden, Sarah P., Ivana Rizzuto, Markand Patel, et al.. (2018). Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study. British Journal of Cancer. 119(7). 815–822. 33 indexed citations
6.
El‐Bahrawy, Mona, et al.. (2017). Ovarian leiomyoma with myxoid stroma.. PubMed. 109(4). 389–391. 2 indexed citations
7.
Jones, Benjamin P., Srdjan Saso, J. Farren, et al.. (2017). Ultrasound-Guided Laparoscopic Ovarian Wedge Resection in Recurrent Serous Borderline Ovarian Tumours. International Journal of Gynecological Cancer. 27(9). 1813–1818. 11 indexed citations
8.
Westaby, Joseph, et al.. (2016). Primary Ovarian Malignant PEComa: A Case Report. International Journal of Gynecological Pathology. 36(4). 400–404. 9 indexed citations
9.
Francis, Nick, et al.. (2016). Rare Skin Adnexal and Melanocytic Tumors Arising in Ovarian Mature Cystic Teratomas: A Report of 3 Cases and Review of the Literature. International Journal of Gynecological Pathology. 35(5). 448–455. 3 indexed citations
10.
El‐Bahrawy, Mona, Steve E. Kalloger, Najla Aldaoud, et al.. (2014). Current Morphologic Criteria Perform Poorly in Identifying Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome-associated Uterine Leiomyomas. International Journal of Gynecological Pathology. 33(6). 560–567. 17 indexed citations
11.
El‐Bahrawy, Mona, et al.. (2014). Expression Profile of Mucins in Ovarian Mucinous Tumors. International Journal of Gynecological Pathology. 33(2). 166–175. 15 indexed citations
12.
El‐Bahrawy, Mona & Raji Ganesan. (2014). Frozen section in gynaecology: uses and limitations. Archives of Gynecology and Obstetrics. 289(6). 1165–1170. 4 indexed citations
13.
Zhao, Lan, Ali Ashek, Lei Wang, et al.. (2013). Heterogeneity in Lung 18 FDG Uptake in Pulmonary Arterial Hypertension. Circulation. 128(11). 1214–1224. 109 indexed citations
14.
Zeller, Constanze, Wei Dai, Edward Curry, et al.. (2013). The DNA Methylomes of Serous Borderline Tumors Reveal Subgroups With Malignant- or Benign-Like Profiles. American Journal Of Pathology. 182(3). 668–677. 12 indexed citations
15.
McKie, Arthur B., Sebastian Vaughan, Imoh S. Okon, et al.. (2012). The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer. Cancer Discovery. 2(2). 156–171. 41 indexed citations
16.
Hollingshead, James, Donna Horncastle, Ian Talbot, et al.. (2011). Expression of EGFR, HER2, Phosphorylated ERK and Phosphorylated MEK in Colonic Neoplasms of Familial Adenomatous Polyposis Patients. Journal of Gastrointestinal Cancer. 43(3). 444–455. 10 indexed citations
17.
Barker, Douglas C., Rohini Sharma, Angus McIndoe, et al.. (2009). An Unusual Case of Sex Cord Tumor With Annular Tubules With Malignant Transformation in a Patient With Peutz-Jeghers Syndrome. International Journal of Gynecological Pathology. 29(1). 27–32. 18 indexed citations
18.
Shams, Pari N., Thomas G. Hardy, Mona El‐Bahrawy, & Naresh Joshi. (2006). Syringocystadenoma papilliferum of the eyelid in a young girl. Ophthalmic Plastic and Reconstructive Surgery. 22(1). 67–69. 7 indexed citations
19.
Hagmann, Cornelia, et al.. (2006). Juvenile xanthogranuloma: a case report of a preterm baby. Journal of Pediatric Surgery. 41(3). 573–575. 9 indexed citations
20.
El‐Bahrawy, Mona, et al.. (2003). Expression of β-catenin in basal cell carcinoma. British Journal of Dermatology. 148(5). 964–970. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026